One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer.
Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.
All content for All In Against Cancer is the property of Ochsner Cancer Institute and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer.
Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.
Neuroendocrine tumors represent an uncommon type of cancer that is best managed with a multidisciplinary approach by experts in this disease. There is a wide range of tumor aggressiveness, prognosis, and potential treatment options which largely depends on how the cancer cells appear under the microscope.
In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Lingling Du, and Ochsner interventional radiologist, Dr. Andrew Marsala, about neuroendocrine tumors. Both Dr. Du and Dr. Marsala specialize in the management of neuroendocrine tumors and are members of the Ochsner Neuroendocrine Tumor Team.
Tune in to hear more about the approach to diagnosis and treatment of neuroendocrine tumors.
All In Against Cancer
One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer.
Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.
